Effect of postoperative radiotherapy on survival in patients with completely resected and pathologically confirmed stage N2 non-small-cell lung cancer: a systematic review and meta-analysis

CONCLUSION: Our results suggest that in the postoperative treatment of patients with completely resected and pathologically confirmed stage N2 NSCLC, the addition of PORT provides better local recurrence control and survival benefit, but no benefit for distant metastases. The PORT may be incorporated into the postoperative treatment options for some patients with high-risk factors. However, it needs to be validated by more prospective studies in the future.TRAIL REGISTRATION: CRD42022314095.PMID:37720592 | PMC:PMC10501070 | DOI:10.1177/20406223231195622
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research